Literature DB >> 22771716

Suspended in culture--human pluripotent cells for scalable technologies.

Carmel O'Brien1, Andrew L Laslett.   

Abstract

Human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs), collectively termed human pluripotent stem cells (hPSCs), are typically derived and maintained in adherent and semi-defined culture conditions. Recently a number of groups, including Chen et al., 2012, have demonstrated that hESCs can now be expanded efficiently and maintain pluripotency over long-term passaging as aggregates in a serum-free defined suspension culture system, permitting the preparation of scalable cGMP derived hPSC cultures for cell banking, high throughput research programs and clinical applications. In this short commentary we describe the utility and potential future uses of suspension culture systems for hPSCs.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22771716     DOI: 10.1016/j.scr.2012.06.001

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  10 in total

1.  A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.

Authors:  Hananeh Fonoudi; Hassan Ansari; Saeed Abbasalizadeh; Mehran Rezaei Larijani; Sahar Kiani; Shiva Hashemizadeh; Ali Sharifi Zarchi; Alexis Bosman; Gillian M Blue; Sara Pahlavan; Matthew Perry; Yishay Orr; Yaroslav Mayorchak; Jamie Vandenberg; Mahmood Talkhabi; David S Winlaw; Richard P Harvey; Nasser Aghdami; Hossein Baharvand
Journal:  Stem Cells Transl Med       Date:  2015-10-28       Impact factor: 6.940

Review 2.  Developmental insights from early mammalian embryos and core signaling pathways that influence human pluripotent cell growth and differentiation.

Authors:  Kevin G Chen; Barbara S Mallon; Kory R Johnson; Rebecca S Hamilton; Ronald D G McKay; Pamela G Robey
Journal:  Stem Cell Res       Date:  2014-02-19       Impact factor: 2.020

Review 3.  Genomic integrity of human induced pluripotent stem cells: Reprogramming, differentiation and applications.

Authors:  Clara Steichen; Zara Hannoun; Eléanor Luce; Thierry Hauet; Anne Dubart-Kupperschmitt
Journal:  World J Stem Cells       Date:  2019-10-26       Impact factor: 5.326

Review 4.  Defining synthetic surfaces for human pluripotent stem cell culture.

Authors:  Jack W Lambshead; Laurence Meagher; Carmel O'Brien; Andrew L Laslett
Journal:  Cell Regen (Lond)       Date:  2013-11-22

Review 5.  Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells.

Authors:  Allen Chen; Sherwin Ting; Jasmin Seow; Shaul Reuveny; Steve Oh
Journal:  Stem Cell Res Ther       Date:  2014-01-21       Impact factor: 6.832

6.  Large-scale production of megakaryocytes in microcarrier-supported stirred suspension bioreactors.

Authors:  Dorothee Eicke; Anja Baigger; Kai Schulze; Sharissa L Latham; Caroline Halloin; Robert Zweigerdt; Carlos A Guzman; Rainer Blasczyk; Constança Figueiredo
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

Review 7.  Advances in hPSC expansion towards therapeutic entities: A review.

Authors:  Shelly E Tannenbaum; Benjamin E Reubinoff
Journal:  Cell Prolif       Date:  2022-05-31       Impact factor: 8.755

8.  Development of stem cell-based therapy for Parkinson's disease.

Authors:  Fabin Han; Deborah Baremberg; Junyu Gao; Jing Duan; Xianjie Lu; Nan Zhang; Qingfa Chen
Journal:  Transl Neurodegener       Date:  2015-09-03       Impact factor: 8.014

9.  A 3D sphere culture system containing functional polymers for large-scale human pluripotent stem cell production.

Authors:  Tomomi G Otsuji; Jiang Bin; Azumi Yoshimura; Misayo Tomura; Daiki Tateyama; Itsunari Minami; Yoshihiro Yoshikawa; Kazuhiro Aiba; John E Heuser; Taito Nishino; Kouichi Hasegawa; Norio Nakatsuji
Journal:  Stem Cell Reports       Date:  2014-04-24       Impact factor: 7.765

10.  Long-Term Maintenance of Human Pluripotent Stem Cells on cRGDfK-Presenting Synthetic Surfaces.

Authors:  Jack W Lambshead; Laurence Meagher; Jacob Goodwin; Tanya Labonne; Elizabeth Ng; Andrew Elefanty; Edouard Stanley; Carmel M O'Brien; Andrew L Laslett
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.